Nitrendipine

A3AR, A3R, AA3R_HUMAN, ABC member 16, MDR/TAP subfamily, ABC16, ABCB1, ABCBB_HUMAN, AD 026, ADORA 3, AI838772, AIS, ANDR_HUMAN, ANKTM 1, AR, AR JP, AR8, ARA3, ATP binding cassette sub family B (MDR/TAP) member 11, ATP-binding cassette sub-family B member 11, AW493413, Abacavir hypersensitivity, susceptibility to, Adenosine A3 receptor, Adenosine receptor A3, Aland island eye disease (Forsius Eriksson ocular albinism, ocular albinism type 2), Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Ankyrin-like with transmembrane domains protein 1, BRIC2, BXR, Beta-interferon, Bile salt export pump, Bsep, CAC1C_HUMAN, CAC1D_HUMAN, CAC1F_HUMAN, CAC1S_HUMAN, CACH 2, CACH1, CACH3, CACN 2, CACN1, CACN4, CACNA 1D, CACNAF, CACNAF1, CACNL1A1, CACNL1A2, CACNL1A3, CCHL1A1, CCHL1A2, CCHL1A3, CDCD2, CMD1E, CMPD2, COD 3, CORDX, CORDX 3, CSNB2A, CSNBX 2, CaV1.2, Cach1b, Calcium channel, Calcium channel L type alpha 1 polypeptide isoform 1 cardiac muscle, Calcium channel L type alpha 1 polypeptide isoform 2, Calcium channel cardic dihydropyridine sensitive alpha 1 subunit, Calcium channel neuroendocrine/brain type alpha 1 subunit, Calcium channel voltage dependent L type alpha 1, Calcium channel voltage dependent L type alpha 1C subunit, Calcium channel voltage dependent L type alpha 1D subunit, Calcium channel voltage dependent L type alpha 1F subunit, Calcium channel voltage dependent alpha 1F subunit, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal muscle, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal muscle, hypokalemic periodic paralysis, Calcium channel, skeletal muscle dihydropyridine sensitive , alpha 1 subunit, Calcium channel, voltage dependent, L type, alpha 1S subunit, Calcium channel, voltage-dependent, L type, alpha 1S subunit, b, Cardiac tetrodotoxin insensitive voltage dependent sodium channel alpha subunit, Cav1.1, Cav1.3, Cav1.4, Cav1.4alpha1, DHPR alpha 1, DHPR alpha 1 subunit, DHTR, Dihydro testosterone receptor, Dihydropyridine receptor, Dihydropyridine sensitive L type calcium channel alpha 1 subunit, Dihydrotestosterone receptor (DHTR), Drug-induced liver injury due to flucloxacillin, E3 ubiquitin ligase, E3 ubiquitin-protein ligase parkin, EIEE6, Eag-related protein 1, Ether a go go related potassium channel protein, Ether-a-go-go-related gene potassium channel 1, Ether-a-go-go-related protein 1, FEB3, FEB3A, FHM3, FLJ11090, FRA6E, Fibroblast interferon, G-protein coupled receptor 55, GEFS+2, GEFSP2, GPCR 2, GPCR GPR55, GPR55_HUMAN, H-ERG, HB 1, HB2, HBBD, HBSC I, HBSC II, HH1, HLA class I histocompatibility antigen, B-13 alpha chain, HLA class I histocompatibility antigen, B-14 alpha chain, HLA class I histocompatibility antigen, B-15 alpha chain, HLA class I histocompatibility antigen, B-18 alpha chain, HLA class I histocompatibility antigen, B-27 alpha chain, HLA class I histocompatibility antigen, B-35 alpha chain, HLA class I histocompatibility antigen, B-37 alpha chain, HLA class I histocompatibility antigen, B-38 alpha chain, HLA class I histocompatibility antigen, B-40 alpha chain, HLA class I histocompatibility antigen, B-41 alpha chain, HLA class I histocompatibility antigen, B-42 alpha chain, HLA class I histocompatibility antigen, B-44 alpha chain, HLA class I histocompatibility antigen, B-45 alpha chain, HLA class I histocompatibility antigen, B-46 alpha chain, HLA class I histocompatibility antigen, B-47 alpha chain, HLA class I histocompatibility antigen, B-48 alpha chain, HLA class I histocompatibility antigen, B-49 alpha chain, HLA class I histocompatibility antigen, B-50 alpha chain, HLA class I histocompatibility antigen, B-51 alpha chain, HLA class I histocompatibility antigen, B-52 alpha chain, HLA class I histocompatibility antigen, B-53 alpha chain, HLA class I histocompatibility antigen, B-54 alpha chain, HLA class I histocompatibility antigen, B-55 alpha chain, HLA class I histocompatibility antigen, B-56 alpha chain, HLA class I histocompatibility antigen, B-57 alpha chain, HLA class I histocompatibility antigen, B-58 alpha chain, HLA class I histocompatibility antigen, B-59 alpha chain, HLA class I histocompatibility antigen, B-67 alpha chain, HLA class I histocompatibility antigen, B-7 alpha chain, HLA class I histocompatibility antigen, B-73 alpha chain, HLA class I histocompatibility antigen, B-78 alpha chain, HLA class I histocompatibility antigen, B-8 alpha chain, HLA class I histocompatibility antigen, B-81 alpha chain, HLA class I histocompatibility antigen, B-82 alpha chain, HOKPP, HUMARA, HYSP1, HypoPP, ICCD, IFB, IFF, IFN-beta, IFNB 1, IFNB_HUMAN, IVF, Interferon beta, Interferon beta 1 fibroblast, Interferon beta precursor, JM 8, JMC 8, KCNH2_HUMAN, KD, KIAA1356, Kennedy disease (KD), Kv11.1, L type, LPIR1, LPRS 2, LQT 2, LQT3, LQT8, Lymphocyte antigen, MED, MGC104252, MGC112732, MGC96956, MHC class I antigen B 7, MHS5, Major Histocompatibility Complex Class I B, Malignant hyperthermia susceptibility 5, NAC3, NE NA, NR1I2_HUMAN, NR3C4, Nav 1.1, Neuroendocrine sodium channel, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), ONR 1, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, PAR, PAR q, PARK 2, PASNA, PDJ, PFHB1, PFIC 2, PGY4, PN 5, PN1, PN3, PRKN 2, PRKN2_HUMAN, PRR, Parkin 2, Parkinson disease (autosomal recessive juvenile) 2, Parkinson disease (autosomal recessive, juvenile) 2, parkin, Parkinson disease protein 2, Parkinson juvenile disease protein 2, Parkinson protein 2 E3 ubiquitin protein ligase, Parkinson protein 2, E3 ubiquitin protein ligase (parkin), Peripheral nerve sodium channel 3, Peripheral nerve sodium channel 5, Peripheral sodium channel 1, Potassium channel HERG, Potassium voltage gated channel subfamily H (eag related) member 2, Potassium voltage-gated channel subfamily H member 2, Pregnane X receptor, Probable G protein coupled receptor 55, RBI, ROB1, RP11 552M11.7, RP24-311F12.2, SANDD, SBMA, SCAN1, SCN 11A, SCN 12A, SCN1, SCN10A, SCN1A_HUMAN, SCN2A1, SCN2A2, SCN5A_HUMAN, SMAX1, SMEI, SNS 2, SQT1, SSS1, SXR, Scn5a (gene name), Sensory neuron sodium channel 2, Sister of P glycoprotein, SkM1, Sodium channel protein brain I alpha subunit, Sodium channel protein brain I subunit alpha, Sodium channel protein brain II subunit alpha, Sodium channel protein brain III subunit alpha, Sodium channel protein cardiac muscle alpha subunit, Sodium channel protein cardiac muscle subunit alpha, Sodium channel protein skeletal muscle subunit alpha, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha, Sodium channel protein type 11 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha, Sodium channel protein type 4 subunit alpha, Sodium channel protein type 5 subunit alpha, Sodium channel protein type 8 subunit alpha, Sodium channel protein type 9 subunit alpha, Sodium channel protein type I subunit alpha, Sodium channel protein type II subunit alpha, Sodium channel protein type III subunit alpha, Sodium channel protein type IV subunit alpha, Sodium channel protein type IX subunit alpha, Sodium channel protein type V alpha subunit, Sodium channel protein type V subunit alpha, Sodium channel protein type VIII subunit alpha, Sodium channel protein type X subunit alpha, Sodium channel protein type XI subunit alpha, Sodium channel voltage gated type 1 alpha subunit, Sodium channel voltage gated type I alpha polypeptide, Spgp, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, Synovitis, chronic, susceptibility to, TFM, TGPCR1, TRPA1_HUMAN, TS, TTPP1, TYDP, TYDP1_HUMAN, Testicular Feminization (TFM), Transformation-sensitive protein p120, Transient receptor potential cation channel subfamily A member 1, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, Ubiquitin E3 ligase PRKN, VF1, Voltage dependent L type calcium channel alpha 1C subunit, Voltage ependent L ype calcium channel subunit alpha F, Voltage gated L type calcium channel Cav1.2 alpha 1 subunit, splice variant 10*, Voltage gated calcium channel alpha 1 subunit, Voltage gated calcium channel alpha 1F subunit, Voltage gated calcium channel alpha subunit Cav1.2, Voltage gated calcium channel alpha subunit Cav1.3, Voltage gated calcium channel subunit alpha Cav1.4, Voltage gated potassium channel, subfamily H, member 2, Voltage gated sodium channel alpha subunit Nav1.5, Voltage-dependent L-type calcium channel subunit alpha-1C, Voltage-dependent L-type calcium channel subunit alpha-1D, Voltage-dependent L-type calcium channel subunit alpha-1S, Voltage-gated calcium channel subunit alpha Cav1.1, Voltage-gated calcium channel subunit alpha Cav1.2, Voltage-gated calcium channel subunit alpha Cav1.3, Voltage-gated potassium channel subunit Kv11.1, Voltage-gated sodium channel subtype III, Voltage-gated sodium channel subunit alpha Nav1.1, Voltage-gated sodium channel subunit alpha Nav1.2, Voltage-gated sodium channel subunit alpha Nav1.3, Voltage-gated sodium channel subunit alpha Nav1.4, Voltage-gated sodium channel subunit alpha Nav1.5, Voltage-gated sodium channel subunit alpha Nav1.6, Voltage-gated sodium channel subunit alpha Nav1.7, Voltage-gated sodium channel subunit alpha Nav1.8, Voltage-gated sodium channel subunit alpha Nav1.9, alpha-1 polypeptide, androgen receptor splice variant 4b, bA552M11.5, brain sodium channel type I, cardiac muscle, eag homolog, fmd, hERG-1, hNE-Na, hNaN, hPN3, isoform 1, isoform 2, isoform 3, leukocyte antigen class I-B, pregnane X nuclear receptor variant 2, progressive familial intrahepatic cholestasis 2, sj

Biochemicals